Annotation Detail

Information
Associated Genes
MAP2K1
Associated Variants
MAP2K1 MUTATION
MAP2K1 MUTATION
Associated Disease
Leukemia, Lymphocytic, Acute, L1
Source Database
DisGeNET
Description
Furthermore, we demonstrate that inhibition of MEK1/2 with trametinib increased sensitivity of ALL cells and primary samples to chemotherapy in vitro and in vivo.
Pubmed
26324703
Section of the abstract supporting the evidence
ALL_TEXT_3/3
Number of the section of the abstract supporting the evidence
3
Number of the sentence supporting the evidence
8
Original source reporting the Gene Disease association
BeFree
DisGENET score for the Gene Disease association
0.000271441872080303
Drugs